Comparison of VEGF-producing cells in periprosthetic osteolysis

Biomaterials

Volumn 27, Issue 21, 2006, Pages 3882-3887

  Spanogle, J P ^a   Miyanishi, K ^a   Ma, T ^a   Epstein, N J ^a   Smith, R L ^a   Goodman, S B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelium; Fibroblast; Fluroscence; Macrophage; Osteolysis; VEGF (Vascular endothelial growth factor)

Indexed keywords

BIOLOGICAL MEMBRANES; BONE; GROWTH KINETICS; IMMUNOLOGY; IMPLANTS (SURGICAL);

FIBROBLAST; MACROPHAGE; OSTEOLYSIS; VEGF (VASCULAR ENDOTHELIAL GROWTH FACTOR);

CELLS;

CD11B ANTIGEN; CHLORDANE; ISOPROTEIN; MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; ASEPSIS; CELL ACTIVITY; CELL COUNT; CELL FUNCTION; CELL TYPE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; GENE FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMPLANT; MACROPHAGE; MALE; OSTEOARTHRITIS; OSTEOLYSIS; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROSTHESIS LOOSENING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REOPERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; SYNOVIUM; TOTAL HIP PROSTHESIS;

AGED; AGED, 80 AND OVER; CELLS, CULTURED; FEMALE; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOLYSIS; PROSTHESIS-RELATED INFECTIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646023986     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.02.035     Document Type: Article

References (39)

1. Harris W.H. The problem is osteolysis. Clin Orthop Relat Res 311 (1995) 46-53
2. Clohisy J.C., Calvert G., Tull F., McDonald D., and Maloney W.J. Reasons for revision hip surgery: a retrospective review. Clin Orthop Relat Res 429 (2004) 188-192
3. Waddell J., Pritzker K.P., and Boynton E.L. Increased cytokine secretion in patients with failed implants compared with patients with primary implants. Clin Orthop Relat Res 434 (2005) 170-176
4. Wang M.L., Sharkey P.F., and Tuan R.S. Particle bioreactivity and wear-mediated osteolysis. J Arthroplasty 19 (2004) 1028-1038
5. Goodman S.B. Wear particulate and osteolysis. Orthop Clin North Am 36 (2005) 41-48
6. Konttinen Y.T., Zhao D., Beklen A., Ma G., Takagi M., Kivela-Rajamaki M., et al. The microenvironment around total hip replacement prostheses. Clin Orthop Relat Res 430 (2005) 28-38
7. Goodman S.B., Lind M., Song Y., and Smith R.L. In vitro, in vivo, and tissue retrieval studies on particulate debris. Clin Orthop Relat Res 352 (1998) 25-34
8. Santavirta S., Konttinen Y.T., Hoikka V., and Eskola A. Immunopathological response to loose cementless acetabular components. Br J Bone Joint Surg 73 (1991) 38-42
9. Santavirta S., Eskola A., Konttinen Y.T., and Lindholm T. Proliferative cell response to loosening of total hip replacements: a cytofluorographic cell cycle analysis. Arch Orthop Trauma Surg 111 (1991) 43-46
10. Revell P.A. Tissue reactions to joint prostheses and the products of wear and corrosion. In: Berry C. (Ed). Current trends in pathology (1982), Springer-Verlag, Berlin
11. Amstutz H.C., Campbell P., Kossovsky N., and Clarke I.C. Mechanisms and clinical significance of wear debris-induced osteolysis. Clin Orthop Relat Res 276 (1992) 7-18
12. Bullough P.G., DiCarlo E.F., Hansraj K.K., and Neves M.C. Pathologic studies of total joint replacement. Orthop Clin North Am 19 (1988) 611-625
13. Goodman S.B., Huie P., Song Y., Lee K., Doshi A., Rushdieh B., et al. Loosening and osteolysis of cemented joint arthroplasties. A biologic spectrum. Clin Orthop Relat Res 337 (1997) 149-163
14. Goodman S.B., Huie P., Song Y., Schurman D., Maloney W., Woolson S., et al. Cellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacements. J Bone Joint Surg Br 80 (1998) 531-539
15. Xu J.W., Konttinen Y.T., Lassus J., Natah S., Ceponis A., Solovieva S., et al. Tumor necrosis factor-alpha (TNF-alpha) in loosening of total hip replacement (THR). Clin Exp Rheumatol 14 (1996) 643-648
16. Epstein N.J., Warme B.A., Spanogle J., Ma T., Bragg B., Smith R.L., et al. Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res 23 (2005) 501-510
17. Al-Saffar N., Mah J.T.L., Kadoya Y., and Revell P.A. Neovascularisation and the induction of cell adhesion molecules in response to degradation products from orthopaedic implants. Ann Rheum Dis 54 (1995) 201-208
18. Jell G.M., and Al-Saffar N. Does a pro-angiogenic state exist in the bone-implant interface of aseptically loosened joint prosthesis?. J Mater Sci Mater Med 12 (2001) 1069-1073
19. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
20. Berse B., Hunt J.A., Diegel R.J., Morganelli P., Yeo K., Brown F., et al. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1) -induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 115 (1999) 176-182
21. Seghezzi G., Patel S., Ren C.J., Gualandris A., Pintucci G., Robbins E.S., et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141 (1998) 1659-1673
22. Tanaka E., Aoyama J., Miyauchi M., Takata T., Hanaoka K., Iwabe T., et al. Vascular endothelial growth factor plays an important autocrine/paracrine role in the progression of osteoarthritis. Histochem Cell Biol 123 (2005) 275-281
23. Matsumoto Y., Tanaka K., Hirata G., Hanada M., Matsuda S., Shuto T., et al. Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints. J Immunol 168 (2002) 5824-5831
24. Nakagawa M., Kaneda T., Arakawa T., Morita S., Sato T., Yomada T., et al. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 473 (2000) 161-164
25. Niida S., Kaku M., Amano H., Yoshida H., Kataoka H., Nishikawa S., et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 190 (1999) 293-298
26. Miyanishi K., Trindade M.C., Ma T., Goodman S.B., Schurman D.J., and Smith R.L. Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles. J Bone Miner Res 18 (2003) 1573-1583
27. Wellmann S., Taube T., Paal K., Einsiedel H.G.V., Geilen W., Seifert G., et al. Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by lightcycler technology. Clin Chem 47 (2001) 654-660
28. Ingham E., and Fisher J. The role of macrophages in osteolysis of total joint replacement. Biomaterials 26 (2005) 1271-1286
29. Schmalzried T.P., Jasty M., and Harris W.H. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of effective joint space. J Bone Joint Surg Am 74 (1992) 849-863
30. Bauer T.W. Particles and periimplant bone resorption. Clin Orthop Relat Res 405 (2002) 138-143
31. Goodman S.B., Lind M., Song Y., and Smith R.L. In vitro, in vivo, and tissue retrieval studies on particulate debris. Clin Orthop Relat Res 352 (1998) 25-34
32. Al-Saffar N., Khwaja H.A., Kadoya Y., and Revell P.A. Assessment of the role of GM-CSF in the cellular transformation and the development of erosive lesions around orthopaedic implants. Am J Clin Pathol 105 (1996) 628-639
33. Xu J.W., Konttinen Y.T., Waris V., Patiala H., Sorsa T., and Santavirta S. Macrophage-colony stimulating factor (M-CSF) is increased in the synovial-like membrane of the periprosthetic tissues in the aseptic loosening of total hip replacement (THR). Clin Rheumatol 16 (1997) 243-248
34. Waris V., Xu J.W., Nordsletten L., Sorsa T., Santavirta S., and Konttinen Y.T. Basic fibroblast growth factor (bFGF) in the synovial-like membrane around loose total hip prostheses. Scand J Rheumatol 25 (1996) 257-262
35. Konttinen Y.T., Waris V., Xu J.W., Jiranek W.A., Sorsa T., Virtanen I., et al. Transforming growth factor-beta 1 and 2 in the synovial-like interface membrane between implant and bone in loosening of total hip arthroplasty. J Rheumatol 24 (1997) 694-701
36. Clauss M., Weich H., Breier G., Knies U., Rockl W., Waltenberger J., et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271 (1996) 17629-17634
37. Matsumoto Y., Tanaka K., Hirata G., Hanada M., Matsuda S., Shuto T., et al. Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints. J Immunol 168 (2002) 5824-5831
38. Neufeld G., Tessler S., Gitay-Goren H., Cohen T., and Levi B.S. Vascular endothelial growth factor and its receptors. Progr Growth Factor Res 5 (1994) 89-97
39. Angel P., and Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072 (1991) 129-157